Hospitalisations of Teenagers and Young Adulthoods in Mayotte After Consumption of an Illegal Drug Called " Chimique ", Which Substances Are Incriminated ? : HOMACHI

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT04547751
Collaborator
ARS (Agence Régionale de Santé) Mayotte (Other)
13
1
8
1.6

Study Details

Study Description

Brief Summary

The study aims (i) to identify which substances leading to hospitalizations at Mayotte are also called "chimique" and (ii) to correlate these substances with clinical pictures in order to favor a better approach of the treatments.

Condition or Disease Intervention/Treatment Phase
  • Other: targeted high-resolution mass spectrometry

Detailed Description

The CEIP-A of Bordeaux (in charge of French overseas departments) has been commissioned by the MILD&CA in 2015 to reinforce the links between local caregivers and the addictoviligance's inquieries. In particular, the CEIP-A has been alerted about a drug called " chimique " in Mayotte, leading to many hospitalizations. Most of the patients are less than 18 year old or are young adulthoods. For all patients who have agreed to participate in this study, the remainder of the blood sample will be reused for a drop of blood on blotting paper; the remainder of the remainder will be stored in the heparinized tube. Medical data collected in the emergency department will also be collected. All the data will be analyzed by the pharmacology and toxicology laboratory of the Bordeaux University Hospital

Study Design

Study Type:
Observational
Actual Enrollment :
13 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Hospitalisations of Teenagers and Young Adulthoods in Mayotte After Consumption of an Illegal Drug Called " Chimique ", Which Substances Are Incriminated ? : HOMACHI
Actual Study Start Date :
Jun 6, 2020
Actual Primary Completion Date :
Feb 5, 2021
Actual Study Completion Date :
Feb 5, 2021

Arms and Interventions

Arm Intervention/Treatment
Adult

Patients aged 18yrs and older hospitalized in the Emergency Department of the Mayotte Hospital Center after taking a chemical or other psychoactive substance and for whom a blood test is required

Other: targeted high-resolution mass spectrometry
difference between the number of new substances identified using targeted analysis by liquid chromatography coupled with high-resolution mass spectrometry versus using targeted analysis. "narcotics-new substance" by liquid chromatography coupled with tandem mass spectrometry

Minor

Patients aged 14-17yrs and older hospitalized in the Emergency Department of the Mayotte Hospital Center after taking a chemical or other psychoactive substance and for whom a blood test is required

Other: targeted high-resolution mass spectrometry
difference between the number of new substances identified using targeted analysis by liquid chromatography coupled with high-resolution mass spectrometry versus using targeted analysis. "narcotics-new substance" by liquid chromatography coupled with tandem mass spectrometry

Outcome Measures

Primary Outcome Measures

  1. number of new substances identified [Baseline]

    number of new substances identified

Secondary Outcome Measures

  1. Active ingredients found [Baseline]

    Number of active ingredients found (including new substances

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients hospitalized in the Emergency Department of the Mayotte Hospital Center after taking a chemical or other psychoactive substance and for whom a blood test is required;

  • Age ≥ 14 years.

Exclusion Criteria:
  • Patient without parental authority for minor patients aged 14yrs; Patient not included in the exception article 59 of the law of January 6th, 1978 modified for patient aged 15yrs and older

Contacts and Locations

Locations

Site City State Country Postal Code
1 CH Mayotte Mayotte France 97600

Sponsors and Collaborators

  • University Hospital, Bordeaux
  • ARS (Agence Régionale de Santé) Mayotte

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT04547751
Other Study ID Numbers:
  • CHUBX 2018/27
First Posted:
Sep 14, 2020
Last Update Posted:
Apr 12, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Bordeaux
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2022